The University of Chicago Header Logo

Connection

Ravi Salgia to Metalloporphyrins

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Metalloporphyrins.
Ravi Salgia
Connection Strength
0.025
Metalloporphyrins
  1. Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer. J Thorac Oncol. 2011 Apr; 6(4):786-9.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.